Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | BRS3 | P32247 | 2/20 | 0.43 |
| ▸ | WDR5 | P61964 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | ATP1A1 | P05023 | 2/20 | 0.42 |
| ▸ | ATP1B1 | P05026 | 2/20 | 0.42 |
| ▸ | ATP1A3 | P13637 | 2/20 | 0.42 |
| ▸ | ATP1B2 | P14415 | 2/20 | 0.42 |
| ▸ | ATP4A | P20648 | 2/20 | 0.42 |
| ▸ | ATP1A2 | P50993 | 2/20 | 0.42 |
| ▸ | ATP4B | P51164 | 2/20 | 0.42 |
| ▸ | ATP1B3 | P54709 | 2/20 | 0.42 |
| ▸ | FXYD2 | P54710 | 2/20 | 0.42 |
| ▸ | ATP1A4 | Q13733 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3386628 | 1.00 | KMT2A (0.44) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL2592828 | 0.89 | KMT2A (0.45) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL21029237 | 0.89 | KMT2A (0.45) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL14344286 | 0.89 | KMT2A (0.45) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL18710710 | 0.88 | KMT2A (0.44) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| Omeprazole Magnesium SCHEMBL30206693 | 0.87 | KMT2A (0.46) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL29474363 | 0.87 | KMT2A (0.43) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL7844981 | 0.86 | KMT2A (0.43) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL7841182 | 0.85 | KMT2A (0.42) | KMT2AMEN1BRS3WDR5CYP2C9 | |
| SCHEMBL7009476 | 0.84 | CYP2C9 (0.45) | KMT2AMEN1BRS3WDR5CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170095485-A1 | METHODS AND COMPOUNDS TO INHIBIT ENVELOPED VIRUS RELEASE | The Research Foundation for the State of University of New York | 2017-04-06 | — | — | US | disclosed |
| EP-2029574-B1 | NOVEL METHOD FOR PREPARATION OF AMMONIUM SALTS OF ESOMEPRAZOLE | ASTRAZENECA AB (SE) | 2010-12-01 | — | — | EP | disclosed |
| US-20090197919-A1 | Novel Method for Preparation of Ammonium Salts of Esomeprazole | ASTRAZENECA AB (SE) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170095485-A1 | METHODS AND COMPOUNDS TO INHIBIT ENVELOPED VIRUS RELEASE | SARS1, EEA1, ZC3HAV1 | KMT2A 4757/4885MEN1 3575/4885BRS3 2878/4885 |
| US-20090197919-A1 | Novel Method for Preparation of Ammonium Salts of Esomeprazole | ATP6AP1, ATP6V1G1, ATP6V1A | KMT2A 1799/4885MEN1 3800/4885BRS3 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.